Retina Pharmaceuticals

Retina Pharmaceuticals is a forward-looking healthcare company located in Addis Ababa, Ethiopia, specializing in trading high-quality diagnostics and life science solutions. As representatives of Illumina, Roche, Evoqua, ELGA, Keeler, and Quantel Medical, Retina Pharmaceuticals brings innovative medical technologies and exceptional service to the region. We focus on advanced genomics, personalized medicine, and biotechnology, offering a comprehensive range of products that include ophthalmic instruments, medical laboratory equipment, and water purification systems. Vision To become a leader in the Ethiopian healthcare industry by making advanced medical technologies and innovative treatments accessible to all and to drive the adoption of genomics in healthcare for a healthier future. Aim Retina Pharmaceuticals aims to improve the quality of life in Ethiopia by providing cutting-edge medical products, genomic tools, and personalized medicine solutions that cater to the unique needs of the local population. Objectives Enhance Diagnostic Capabilities: Improve access to high-quality diagnostic solutions for healthcare facilities across Ethiopia, ensuring timely and accurate patient assessments. Support Healthcare Infrastructure: Collaborate with government agencies and local institutions to strengthen the healthcare system and ensure the availability of essential medical supplies and equipment. Promote Personalized Medicine: Foster the use of genomics and personalized medicine in healthcare by working with local institutions to enable tailored treatment approaches that improve patient outcomes. Strengthen Partnerships: Facilitate collaborations between Retina, healthcare providers, research institutions, and the public sector to drive innovation in diagnostics and treatment. Support Education and Training: Invest in training programs to build local expertise in diagnostics, genomics, and biotechnology, ensuring that the technology is effectively used and maintain